1. Repositório Institucional da UFMG
  2. Publicações Científicas e Culturais
  3. Artigo de Periódico
Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/56586
Full metadata record
DC FieldValueLanguage
dc.creatorMichael Ruberson Ribeiroda Silvapt_BR
dc.creatorJéssica Barreto Ribeiro Dos Santospt_BR
dc.creatorAlessandra Maciel Almeidapt_BR
dc.creatorJuliana Alvares Teodoropt_BR
dc.creatorAdriana Maria Kakehasipt_BR
dc.creatorFrancisco de Assis Acurciopt_BR
dc.date.accessioned2023-07-18T16:47:29Z-
dc.date.available2023-07-18T16:47:29Z-
dc.date.issued2019-
dc.citation.volume59pt_BR
dc.citation.issue48pt_BR
dc.citation.spage1pt_BR
dc.citation.epage9pt_BR
dc.identifier.issn2523-3106pt_BR
dc.identifier.urihttp://hdl.handle.net/1843/56586-
dc.description.resumoBackground: Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The objective of the study was to evaluate the profile of administrative processes for the treatment of PsA, identify the time elapsed in the flow of processes and its associated factors. Methods: A cross-sectional study of medication requests for the treatment of PsA was carried out between November 2014 and December 2016. Linear regression was used to verify the factors associated with time to delivery. Results: A total of 218 cases containing 250 drugs were analyzed. The median time between the medical appointment and the first dispensation was 66days (interquartile range, 44–90). The State proceedings, which includes requesting the drug until the authorization of treatment, was the stage that most contributed to the total time spent. The factors associated with the longer time to delivery of medications were prescriptions coming from clinics and specialty centers, from dermatologists, non-authorized processes and non-persistent patients in the treatment in 12months. Conclusion: The median time to receive medicines for the PsA treatment in Belo Horizonte health region after a medical prescription was higher than 2 months. The time between the solicitation of the medicines and the authorization of the treatment in the SUS (State administrative procedure) was the main component of the total time spent.pt_BR
dc.languageporpt_BR
dc.publisherUniversidade Federal de Minas Geraispt_BR
dc.publisher.countryBrasilpt_BR
dc.publisher.departmentFAR - DEPARTAMENTO DE FARMÁCIA SOCIALpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE APARELHO LOCOMOTORpt_BR
dc.publisher.departmentMED - DEPARTAMENTO DE CLÍNICA MÉDICApt_BR
dc.publisher.initialsUFMGpt_BR
dc.relation.ispartofAdvances in Rheumatologypt_BR
dc.rightsAcesso Abertopt_BR
dc.subjectPsoriatic arthritispt_BR
dc.subjectAntirheumatic agentspt_BR
dc.subjectHealth policypt_BR
dc.subjectPharmaceutical servicespt_BR
dc.subject.otherArtritept_BR
dc.subject.otherAgentes anti-reumaticospt_BR
dc.subject.otherServiços farmaceuticospt_BR
dc.titleAccess to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensationpt_BR
dc.typeArtigo de Periódicopt_BR
dc.url.externahttps://advancesinrheumatology.biomedcentral.com/articles/10.1186/s42358-019-0091-7pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-2550-7249pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5528-0658pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0003-0138-9401pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-0210-0721pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0001-9411-7493pt_BR
dc.identifier.orcidhttps://orcid.org/0000-0002-5880-5261pt_BR
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil the long path up to dispensation.pdf9.19 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.